Unichem Laboratories Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
- Paid Up Capital ₹ 14.08 Cr
- Company Age 62 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 331.00 Cr
- Satisfied Charges ₹ 198.07 Cr
- Revenue Growth 13.13%
- Profit Growth -440.69%
- Ebitda -113.33%
- Net Worth -10.77%
- Total Assets -7.56%
About Unichem Laboratories
Unichem Laboratories Limited (ULL) was founded in India on 22 August 1962 and has a glorious history of 62 years and six months. Its registered office is in Mumbai, Maharashtra, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 506690 and on the National Stock Exchange(NSE) under UNICHEMLAB.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 50.00 Cr and a paid-up capital of Rs 14.08 Cr.
The company currently has active open charges totaling ₹331.00 Cr. The company has closed loans amounting to ₹198.07 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Unichem Laboratories Limited India is Pradeep Bhandari as COMPANY SECRETARY. Prakash Mody, Pranay Godha, Arun Lalchand, and Three other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L99999MH1962PLC012451
- Company No.
012451
- Stock Symbol
BSE : 506690 NSE : UNICHEMLAB
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Aug 1962
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
What products or services does Unichem Laboratories Limited offer?
Unichem Laboratories Limited offers a wide range of products and services, including Architectural & Civil Engineering, Civil Engineering Service, Medical Surgery & Treatment Centres, Medical Treatment Services, Content Writing Service, Research Development Services, Cardiology Treatment, API (Active Pharmaceutical Ingredients), Rheumatism Treatment, Medical Test Services.
Who are the key members and board of directors at Unichem Laboratories?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pabitrakumar Bhattacharyya  | Managing Director | 10-Aug-2023 | Current |
| Pradeep Bhandari | Company Secretary | 01-Aug-2019 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prakash Mody | Director | 01-Jul-2008 | Current |
| Pranay Godha | Director | 10-Aug-2023 | Current |
| Arun Lalchand | Director | 20-Feb-2024 | Current |
| Anand Kusre | Director | 20-Feb-2024 | Current |
| Priti Puri | Director | 21-Mar-2023 | Current |
Financial Performance of Unichem Laboratories.
Unichem Laboratories Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.13% increase. The company also saw a substantial fall in profitability, with a 440.69% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unichem Laboratories?
In 2023, Unichem Laboratories had a promoter holding of 50.94% and a public holding of 49.06%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ipca Laboratories LimitedPranay Godha is a mutual person
Krebs Biochemicals And Industries LimitedPabitrakumar Bhattacharyya is a mutual person
Nesco LimitedArun Lalchand is a mutual person
Arun Todarwal & Co LlpArun Lalchand is a mutual person
Arun Todarwal & Associates LlpArun Lalchand is a mutual person
Bharat Fih LimitedArun Lalchand is a mutual person
Charges (Loans)
₹331.00 Cr
₹198.07 Cr
Charges Breakdown by Lending Institutions
- Others : 280.00 Cr
- Axis Bank Limited : 30.00 Cr
- Bank Of India : 21.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jan 2022 | Others | ₹30.00 Cr | Open |
| 28 Feb 2020 | Axis Bank Limited | ₹30.00 Cr | Open |
| 31 May 2019 | Others | ₹250.00 Cr | Open |
| 16 Jul 2016 | Bank Of India | ₹21.00 Cr | Open |
| 23 Jan 2018 | Citi Bank N.A. | ₹1.00 Cr | Satisfied |
How Many Employees Work at Unichem Laboratories?
Unichem Laboratories has a workforce of 3635 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unichem Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unichem Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
